Depression relapse. Venlafaxine was superior to lithium in reducing symptoms of both bipolar II, depression, and anxiety. According to the results of a recent study published in the Journal of ...

PITTSBURGH and TOKYO, Oct. 9, 2024 /PRNewswire/ -- Viatris Inc. (VTRS) (NASDAQ: VTRS), a global healthcare company, today announced positive top-line results of its Phase 3 study (B2411367) in Japan ...

--Viatris Inc., a global healthcare company, today announced it has filed applications to the Ministry of Health, Labor and Welfare for approval of Effexor SR Capsules, a serotonin-noradrenaline ...

(RTTNews) - Viatris Inc. (VTRS), a healthcare company, Monday said it has submitted Supplemental New Drug Application to Japan's Ministry of Health, Labor and Welfare (MHLW) for Effexor to treat ...

Common side effects include loss of appetite, constipation, dry mouth, dizziness, sweating, and sexual problems. Venlafaxine was approved for medical use in the United States in Venlafaxine is used ...

Terri calls her mother and is crying. “Every day I wake up in the morning with my heart race racing and I’m too stressed to eat. I feel anxious all day and it’s hard to fall asleep. I'm worried that ...

As previously announced, our Phase 3 placebo-controlled, randomized, double-blind, multicenter study of venlafaxine in patients with GAD conducted in Japan (Study B2411367) achieved its primary ...

Aiming to address a significant unmet need for which no other approved treatment option is available for generalized anxiety disorder patients in Japan "The filing of our supplemental New Drug ...